.png)
The race is on to get CRISPR into diagnostics. This would bring countless benefits including quicker and more accurate results for both infectious and non-infectious disease.
NGS has been on a fascinating journey, featuring numerous pioneering players all racing to get their technology to market. A little over 20 years ago, the race began…
I’ve lost count of the times I’ve seen ‘PhD preferred’, while recruiting for positions in R&D and product development. In the modern life science talent market, are PhDs really so important?
I’ve lost count of the times I’ve seen ‘PhD preferred’, while recruiting for positions in R&D and product development. In the modern life science talent market, are PhDs really so important?
Our Principal Consultant, Adam Butler, talks about the miracles of Stem Cell therapy, the issues surrounding it and the most high-profile case in the treatments' existence.
In today's hyper-connected world, what's the point of conferences? Our Associate Director Jack Shute asked experts from across the speciality chemical space and some of his CM Life Science colleagues to find out.
Since the early 2000’s, before Solexa sequenced bacteriophage phiX-174, single cell genomics has been tipped to become one of the most exciting technologies in genetic analysis.
There’s always a ‘next big thing’ in the healthcare, research and life sciences industries but the emergence and development of the biotech sector is one of the few that has the chance to change the world.
Infectious diseases claim the lives of thousands of people around the world every year. Though methods of diagnosis and treatment have come a long way in recent years, there is still work to do.
In November this year, as first broken by the MIT Technology Review, it was revealed that Chinese scientist He Jiankui had been conducting gene-editing research using CRISPR technology on foetuses as late as 24 weeks into pregnancy.
